Recent Quotes (30 days)

You have no recent quotes
chg | %

Finance

Results 1 - 11 of about 11 for Bell Laboratories, Inc
Company Exchange Symbol Last price Quote change Market cap
Berkshire Hathaway Inc. NYSE BRK.A 217,612.00 -1,388.00 (-0.63%) 359.87B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
Berkshire Hathaway Inc. NYSE BRK.B 144.92 -1.01 (-0.69%) 359.80B
Berkshire Hathaway Inc. (Berkshire) is a holding company owning subsidiaries engaged in a number of diverse business activities. The Company is engaged in ...
BERKSHIRE HATHAWAY A DL 5 ETR BRH 198,000.00 +1,939.20 (0.99%)
BERKSHIRE HATHAWAY A DL 5 FRA BRH 195,181.06 +106.38 (0.05%)
BERKSH. H.B NEW DL-,00333 FRA BRYN 130.50 +0.22 (0.17%)
BERKSHIRE -DRN BVMF BERK34 433.02 +8.90 (2.10%)
Roche Holding Ltd. VTX ROG 260.20 +0.20 (0.08%) 224.72B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (ADR) OTCMKTS RHHBY 33.15 -0.31 (-0.91%) 226.25B
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG FRA RHO5
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding Ltd. (Bearer Share) SWX RO 261.50 -0.25 (-0.10%)
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell
Roche Holding AG ETR RHO5 106.90 -0.45 (-0.42%) 0.00
Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and ...
Executive:
John Irving Bell